FURLAN, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 896
EU - Europa 895
AS - Asia 358
AF - Africa 3
SA - Sud America 2
Totale 2.154
Nazione #
US - Stati Uniti d'America 891
SE - Svezia 423
RU - Federazione Russa 203
SG - Singapore 182
CN - Cina 137
IT - Italia 127
FI - Finlandia 40
IE - Irlanda 35
GB - Regno Unito 28
DE - Germania 25
IN - India 11
JP - Giappone 8
FR - Francia 6
SA - Arabia Saudita 5
CA - Canada 4
IR - Iran 4
KR - Corea 4
EG - Egitto 3
NL - Olanda 3
HK - Hong Kong 2
PK - Pakistan 2
PL - Polonia 2
BR - Brasile 1
CL - Cile 1
ES - Italia 1
GR - Grecia 1
ID - Indonesia 1
JO - Giordania 1
MX - Messico 1
TR - Turchia 1
UA - Ucraina 1
Totale 2.154
Città #
Lawrence 174
Princeton 172
Ashburn 162
Shanghai 112
Singapore 104
Moscow 77
Milan 64
New York 52
Boardman 41
Washington 40
Helsinki 37
Dublin 35
Los Angeles 17
Seattle 15
Manchester 11
Pune 7
Rome 7
Austin 5
Jeddah 5
London 5
Borås 4
Edgware 4
Harrow 4
Kunming 4
Chions 3
Lappeenranta 3
Qina 3
Tomblaine 3
Beijing 2
Bergamo 2
Canneto sull'Oglio 2
Central 2
Chandigarh 2
Chaponnay 2
Chuo 2
Clifton 2
Florence 2
Genoa 2
Guangzhou 2
Karachi 2
Mapo-gu 2
Naples 2
Phoenix 2
Salford 2
San Mateo 2
Santa Clara 2
Shinjuku 2
's-Hertogenbosch 1
Andover 1
Arenzano 1
Belleville 1
Berlin 1
Brierley Hill 1
Carate Brianza 1
Cassolnovo 1
Castel Maggiore 1
Cheongju-si 1
Duncan 1
Ely 1
Enschede 1
Erlangen 1
Falkenstein 1
Giulianova 1
Gunzenhausen 1
Gurgaon 1
Halifax 1
Houston 1
Indore 1
Kish 1
Leganés 1
Melikgazi 1
Mexico City 1
Montesilvano 1
Mount Vernon 1
Mountain View 1
Napoli 1
Nuremberg 1
Offenbach 1
Redmond 1
Redwood City 1
Rouyn-Noranda 1
Segrate 1
Tehran 1
Temecula 1
Toronto 1
Vaprio d'Adda 1
Verona 1
Vinnytsia 1
Voghera 1
Zanjan 1
Zola Predosa 1
Totale 1.252
Nome #
Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up 38
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors 30
Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: A multimodal magnetic resonance imaging study 30
A peripheral inflammatory signature discriminates bipolar from unipolar depression: A machine learning approach 28
Clinical Features and Biomarkers to Differentiate Primary and Amyotrophic Lateral Sclerosis in Patients With an Upper Motor Neuron Syndrome 24
One-year mental health outcomes in a cohort of COVID-19 survivors 24
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 21
Neuroinflammation in Bipolar Depression 21
Higher baseline interleukin-1β and TNF-α hamper antidepressant response in major depressive disorder 20
Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients 20
INCREASE OF MYELOID MICROVESICLES IN THE CEREBROSPINAL FLUID AS BIOMARKER OF MICROGLIA/MACROPHAGE ACTIVATION IN NEUROLOGICAL DISORDERS 19
CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study 19
Neurofilaments light: Possible biomarker of brain modifications in bipolar disorder 19
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 18
Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors 18
Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis 18
MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis 18
Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life 18
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients 17
DIFFERENTIAL miRNAs EXPRESSION PROFILE BETWEEN TREG-VERSUS T EFFECTOR CELLS IN COURSE OF MULTIPLE SCLEROSIS 17
Cytokines and immunity in multiple sclerosis: the dual signal hypothesis 17
Absence of oligoclonally restricted immunoglobulins in tears from multiple sclerosis patients 17
A gene therapy approach to treat demyelinating diseases using nonreplicative herpetic vectors engineered to produce cytokines 17
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 17
Dysregulation of MS risk genes and pathways at distinct stages of disease 17
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicantre study 17
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? 17
Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis 17
Mood-congruent negative thinking styles and cognitive vulnerability in depressed COVID-19 survivors: A comparison with major depressive disorder 17
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice 16
Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis 16
Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis 16
AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 Axis 16
CSF extracellular vesicles and risk of disease activity after a first demyelinating event 16
Classical and unconventional pathways of vesicular release in microglia 15
Ventilation With Argon Improves Survival With Good Neurological Recovery After Prolonged Untreated Cardiac Arrest in Pigs 15
A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis 15
T regulatory cells are markers of disease activity in multiple sclerosis patients 15
Stiff-man syndrome and autoimmunity; pathogenetic problems 15
Natural Killer cells protect white matter integrity in Bipolar Disorder 15
Real time RT-PCR determination of mRNA levels of cytokine, chemokine and chemokine receptors in PBLs from MS patients: clinical and MRI correlations 15
Disease-modifying treatments modulate myeloid cells in multiple sclerosis patients 15
Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors 15
Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects 14
Gene transfer to pancreatic islets mediated by a replication incompetent HSV-1 14
Administration of an MCP-1 variant to EAE mice prevents inflammatory cell recruitment and protects from demyelination and axonal loss 14
Cxcl10 enhances blood cells migration in the sub-ventricular zone of mice affected by experimental autoimmune encephalomyelitis 14
Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes. 14
Vitamin D levels and risk of developing multiple sclerosis 14
Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis 14
Allogeneic Hematopoietic Stem Cell Transplantation For Severe Neuromyelitis Optica 14
Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression 14
Plasma neurofilament light chain levels and cognitive testing as predictors of fast progression in Alzheimer’s disease 14
Motor-evoked potentials (MEPs) for monitoring chronic cortico-spinal damage in MOG35-55-induced experimental autoimmune encephalomyelitis (EAE) 13
ALTERED MRNA LEVELS OF CHEMOKINES AND CYTOKINES IN SCHIZOPHRENIA AND BIPOLAR DISORDER 13
ACID SPHINGOMYELINASE TRIGGERS P2X7-INDUCED MICROPARTICLE RELEASE FROM GLIAL CELLS 13
Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach 13
Lentiviral-mediated administration of IL-25 in the CNS induces alternative activation of microglia 13
Activated macrophages release microvesicles containing polarized M1 or M2 mRNAs 13
Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates 13
miR-21 sustains CD28 signalling and low-affinity T-cell responses at the expense of self-tolerance 13
COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: A 2-year study 13
Neuromyelitis optica spectrum disorder: the importance of NMO-IgG in clinical practice 12
Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndrome 12
Neural progenitor cells orchestrate microglia migration and positioning into the developing cortex 12
Activation of invariant NKT cells by alpha GalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma 12
Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes 12
Artificial intelligence techniques in the diagnosis of multiple sclerosis 12
Animal models of multiple sclerosis 12
Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss 12
Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis 12
Synapsin I deletion reduces neuronal damage and ameliorates clinical progression of experimental autoimmune encephalomyelitis 12
Prognostic Value of Vitamin D in Clinically Isolated Syndromes (CIS) 12
LONG-TERM DISEASE CONTROL OF REFRACTORY NEUROMYELITIS OPTICA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 12
Diagnostic value of IgG4 Indices in IgG4-related hypertrophic pachymeningitis. 12
Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes 12
The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms 11
Evaluation of different techniques to detect anti-acquaporin 4 antibodies in neuromyelitis optica patients 11
Evaluation of different techniques to detect anti-aquaporin 4 antibodies 11
Inflammation affects striatal glutamate transmission since the pre-clinical phase of experimental autoimmune encephallonlyelitis 11
Mesenchymal stem cells as treatment for multiple sclerosis: Immunomodulation versus tissue repair 11
MICROVESICLES IN THE CEREBROSPINAL FLUID REFLECT MICROGLIA/MACROPHAGE ACTIVATION IN RODENT AND HUMAN NEURO-INFLAMMATION 11
Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination 11
Method for intracellular labeling of lymphocytes using Endorem(R) and Feridex(R): Possible applications for MRI studies in multiple sclerosis (MS) 11
Subclinical central inflammation is risk for RIS and CIS conversion to MS 11
In vivo fate analysis reveals the multipotent and self-renewal features of embryonic AspM expressing cells 11
Similar low frequency of anit-MOG IgG and IgM in MS patients and healthy subjects 11
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis 11
Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment. 11
Cytokine gene delivery into the central nervous system using intrathecally injected non-replicative viral vectors 11
Central Nervous system delivery of Interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination 11
Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients 11
Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis 11
2D immunomic approach for the study of IgG autoantibodies in the experimental model of multiple sclerosis 11
A helper dependent adenovirus efficiently delivers bioactive FGF-II to the CNS 10
Opposite changes of glutamate and GABA transmission in the striatum of mice with experimental autoimmune encephalomyelitis 10
B cell depletion attenuates CD27 signaling of T helper cells in multiple sclerosis 10
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis 10
Clinical and functional recovery from experimental autoimmune encephalomyelitis by intracisternal delivery of IL4 from a helper-dependent adenoviral vector. A pre-clinical model of gene therapy of multiple sclerosis 10
MICROGLIAL MICROPARTICLES AS POTENTIAL BIOMARKER FOR NEUROINFLAMMATORY AND NEURODEGENERATIVE DISEASES 10
Totale 1.488
Categoria #
all - tutte 40.952
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.952


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 5 1 0 0 0 0 0 0 0 6 0 1
2020/202118 0 0 0 3 0 0 5 0 8 0 2 0
2021/2022162 6 4 1 57 14 18 16 5 7 15 7 12
2022/20231.070 398 175 50 6 8 85 37 49 28 24 201 9
2023/2024784 7 44 108 61 103 174 20 62 8 26 34 137
2024/2025361 361 0 0 0 0 0 0 0 0 0 0 0
Totale 2.461